/PRNewswire/ The Premier Lacrosse League (PLL) powered by Ticketmaster announced today that the league will partner with Q30 Innovations to raise awareness.
Share this article
Share this article
WESTPORT, Conn., March 1, 2021 /PRNewswire/ Q30 Innovations is pleased to announce the FDA s recent authorization to market the Q-Collar in the United States. The FDA clearance is a major step forward in the company s mission to help better protect athletes from the effects of repeated head impacts.
The FDA s decision was based on a rigorous review of eight years of scientific research and clinical trials that demonstrate the safety and efficacy of the Q-Collar, including prospective, longitudinal studies in the United States with approximately 450 male and female athletes. The football study showed that over the course of a season of play, 77% of the collar wearing athletes had no significant changes in their deep brain tissues (white matter), compared to 73% of non-collar wearing participants who experienced significant changes. No adverse events have been associated with the use of the Q-Collar.